In the Phase 2 obesity trial it produced about 24% weight loss at 12 mg over 48 weeks, the most of any drug in the class, and it cut liver fat by 86% in the people who started with fatty liver. In the 80-week Phase 3 obesity trial of 2,300 adults with an average BMI of 40, 12 mg produced 28% weight loss and 9 mg reached 26%
This is in stark contrast to ConsumerLab
The I VIT 12 COMBINATION PACK INJECTION 2.5ML is a formulation that contains cyanocobalamin or vitamin B12, folic acid, niacinamide, and ascorbic acid or vitamin C, useful for managing vitamin deficiencies
These combination products are generally promoted for their antioxidant, anti-inflammatory, or neuroprotective properties, rather than for gynecological or endocrine-related indications